The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations of amphetamine and methylphenidate – to warn about the risk of weight loss and other adverse reactions (side effects) in patients yo
Similar Posts
Overview of our role regulating and approving drugs | Video series
Learn how the FDA regulates drugs using science and data to ensure their safety, quality and efficacy. FDA plays a vital role in drug development and approval process. Watch our informative video series on FDA drugs, FDA approval, and the drug development process.Lil’ Turtles Issues a Voluntary Recall Due to Undeclared Milk Allergen
Baltic, OH (Dec. 4, 2025) – Lil’ Turtles is recalling all lots of its Grandma Belle’s Tomato Basil Soup for misbranding due to the milk allergen not being declared on the label. The Grandma Belle’s Tomato Basil Soup was packaged in 17 oz glass jars.www.24hreup.biz – 700358 – 04/23/2025
Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the InternetKonrad Rejdak, MD, PhD – 671405 – 05/01/2025
Bioresearch Monitoring Program/IRBSprout Health Partners LLC dba Sprout Health – 09/09/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetState Importation Program Enhancements
FDA is committed to continuing to work with states and Indian tribes that seek to develop an importation proposal under section 804 of the Federal Food, Drug and Cosmetic Act.